This is the website for the ‘Evaluating Optimal Vaccine Schedules against Ebola’ (EVOLVE) study at the Oxford Vaccine Group, part of the University of Oxford.



Thank you for your interest in the Study titled ‘Evaluating Optimal Vaccine schedules against Ebola’ (EVOLVE). The study is now fully recruited and further recruitment is closed.
If you would like to be contacted about future studies, please sign up to our newsletter